Dr. Paba-Prada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave, Dana-Farber Cancer Institute
Dana 1b
Boston, MA 02215Phone+1 617-632-4061- Is this information wrong?
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2007 - 2010
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007
Industrial University of Santander Faculty of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2009 - 2026
MA State Medical License 2010 - 2022
TN State Medical License 2009 - 2010
PA State Medical License 2004 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsRisk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.Matthew Ho, Maria Moscvin, Soon Khai Low, Benjamin Evans, Sara Close, Robert Schlossman, Jacob Laubach, Claudia Paba Prada, Brett Glotzbecker, Paul G Richardson, Giada...> ;Leukemia & Lymphoma. 2022 Oct 1
- 56 citationsMelflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.Paul G. Richardson, Sara Bringhen, Peter M. Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Claudia E. Paba-Prada, Hanan Zubair, Catriona Byrne, Dharmin...> ;The Lancet. Haematology. 2020 Mar 23
- 53 citationsPhase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myelomaEric K. Rowinsky, Agne Paner, Jesus G. Berdeja, Claudia E. Paba-Prada, Parameswaran Venugopal, Kimmo Porkka, Joachim Gullbo, Stig Linder, Angelica Loskog, Paul G. Rich...> ;Investigational New Drugs. 2020 Mar 3
- Join now to see all
Abstracts/Posters
- Updated Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVd-lite) in Transplant-Ineligible Multiple MyelomaClaudia E. Paba-Prada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Results from Phase 1/2 Trial of Tagraxofusp in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaClaudia E. Paba-Prada, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Hospital Affiliations
H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Memorial Hospital WestPembroke Pines, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
